Première conférence virtuelle « Quadient Connects » : aider les entreprises à innover toujours plus et accélérer leur transformation digitale
15 avr. 2024 02h30 HE
|
QUADIENT
Quadient (Euronext Paris : QDT), un leader des solutions d’entreprise visant à faire de chaque interaction client – via un canal physique ou digital – une expérience riche et personnalisée, organise...
First ‘Quadient Connects’ Virtual Conference Will Help Organizations Be More Innovative and Accelerate their Digital Transformation
15 avr. 2024 02h30 HE
|
QUADIENT
Quadient (Euronext Paris: QDT), a leader in helping businesses create meaningful customer connections through digital and physical channels, is hosting the first-of-its-kind Quadient Connects virtual...
One Futurist Event—All the Sustainability Trends
11 avr. 2024 14h13 HE
|
Green Builder Media
Lake City, Colo., April 11, 2024 (GLOBE NEWSWIRE) -- Check out this entertaining and educational lineup and grab your virtual seat at the 8th Annual Sustainability Symposium. Free to all attendees,...
Impact of AI, Advancements in Healthcare Taking Center Stage at AAPA 2024
10 avr. 2024 09h18 HE
|
American Academy of PAs
ALEXANDRIA, Va., April 10, 2024 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA) will explore cutting-edge advancements reshaping the foundations of healthcare during AAPA...
Kura Oncology to Participate in Stifel Targeted Oncology Forum
10 avr. 2024 07h30 HE
|
Kura Oncology, Inc.
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
10 avr. 2024 07h25 HE
|
ALTERITY THERAPEUTICS LIMITED
MELBOURNE, Australia and SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at Eyecelerator 2024, a Partner Meeting of the American Society for Cataract and Refractive Surgery
02 avr. 2024 07h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Civitas Networks for Health to Host 2024 Annual Conference in Detroit This October
28 mars 2024 13h29 HE
|
Civitas Networks for Health
Civitas Networks for Health is hosting its Annual Conference October 15-17, 2024. Learn more via the press release.
RTOERO hosts inaugural Future of Aging Summit in Toronto
27 mars 2024 09h00 HE
|
RTOERO
Toronto, Canada, March 27, 2024 (GLOBE NEWSWIRE) -- With nearly 25 per cent of Canadians becoming seniors by 2030, and a global demographic shift towards an aging population, the need for innovative...
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
27 mars 2024 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing,...